Testes in vivo foram realizados para avaliar resistência a drogas antimalária, em pessoas com malária não complicada, causada por Plasmodium falciparum, numa região isolada da Bacia Amazônica, na fronteira com o Brasil e a Colômbia. Os testes mostraram resistência >50% RII/RIII a sulfadoxina-pirimetamina, mas não evidenciaram resistência a mefloquina.

In vivo antimalarial drug efficacy studies of uncomplicated Plasmodium falciparum malaria at an isolated site in the Amazon basin of Peru bordering Brazil and Colombia showed >50% RII/RIII resistance to sulfadoxine-pyrimethamine but no evidence of resistance to mefloquine.

We report a case of an 11 year old male who presented with bacteremia by S. epidermidis and soft tissue abscesses after a bone autograft procedure. The patient received only medical treatment, resolving the abscesses successfully. We also did a review of the literature on S. epidermidis bacteremia, an entity which has acquired increasing importance in the etiology of hospital infections. (Rev Med Hered 2003; 14:221-223).

In this review we present the main historical, epidemiological, clinical and control& prevention aspects of this new disease known as Severe Acute Respiratory Syndrome (SARS). This has been considered the first epidemic infectious disease of the XXI century caused by a virus that principally has affected some areas of China (including Taiwan and Hong Kong), Vietnam, Singapur and Canada (Toronto). The discovered agent is a new virus belonged to the coronavirus family. An effective treatment has not been found yet. ( Rev Med Hered 2003; 14: 89-93).